S&P 500

5.222,68

0,16%

Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.

Cadastre-se

Início
Investir
Ações
EUA
USOTC
Alterity Therapeutics Ltd (PK) (PRNAF)
Alterity Therapeutics Ltd (PK) (PRNAF) Notícias

PRNAF

Alterity Therapeutics (PK) (PRNAF)

Alterity Therapeutics Ltd (PK)

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:USOTC:PRNAF

1

Data	Hora	Fonte	Título	Código	Companhia
04/03/2024	10:01	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:PRNAF	Alterity Therapeutics Ltd (PK)
02/10/2023	09:44	Edgar (US Regulatory)	Form F-3 - Registration statement by foreign private issuers	USOTC:PRNAF	Alterity Therapeutics Ltd (PK)
31/08/2023	10:15	Edgar (US Regulatory)	Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]	USOTC:PRNAF	Alterity Therapeutics Ltd (PK)
21/06/2023	07:09	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	USOTC:PRNAF	Alterity Therapeutics Ltd (PK)
31/08/2022	13:25	Edgar (US Regulatory)	Annual and Transition Report (foreign Private Issuer) (20-f)	USOTC:PRNAF	Alterity Therapeutics Ltd (PK)
26/08/2022	18:19	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	USOTC:PRNAF	Alterity Therapeutics Ltd (PK)
03/06/2022	07:06	Edgar (US Regulatory)	Amended Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k/a)	USOTC:PRNAF	Alterity Therapeutics Ltd (PK)
06/01/2021	18:16	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	USOTC:PRNAF	Alterity Therapeutics Ltd (PK)
23/12/2020	18:07	Edgar (US Regulatory)	Securities Registration (foreign Private Issuer) (f-3)	USOTC:PRNAF	Alterity Therapeutics Ltd (PK)
16/12/2020	18:50	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	USOTC:PRNAF	Alterity Therapeutics Ltd (PK)
02/12/2020	18:07	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	USOTC:PRNAF	Alterity Therapeutics Ltd (PK)
24/11/2020	08:03	Edgar (US Regulatory)	Notice of Effectiveness (effect)	USOTC:PRNAF	Alterity Therapeutics Ltd (PK)
26/05/2020	07:16	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	USOTC:PRNAF	Alterity Therapeutics Ltd (PK)
18/04/2019	17:47	Edgar (US Regulatory)	Statement of Beneficial Ownership (sc 13d)	USOTC:PRNAF	Alterity Therapeutics Ltd (PK)
27/03/2019	07:10	Edgar (US Regulatory)	Amended Report of Foreign Issuer (6-k/a)	USOTC:PRNAF	Alterity Therapeutics Ltd (PK)
06/11/2014	13:10	Edgar (US Regulatory)	Securities Registration (ads, Immediate) (f-6ef)	USOTC:PRNAF	Alterity Therapeutics Ltd (PK)
31/10/2014	19:00	Edgar (US Regulatory)	Notification That Form 20-f Will Be Submitted Late (nt 20-f)	USOTC:PRNAF	Alterity Therapeutics Ltd (PK)
24/07/2014	16:39	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	USOTC:PRNAF	Alterity Therapeutics Ltd (PK)